Tumor suppressor microRNAs: A novel non-coding alliance against cancer

FEBS Letters

Volumn 588, Issue 16, 2014, Pages 2639-2652

  Blandino, Giovanni ^a   Fazi, Francesco ^b   Donzelli, Sara ^a   Kedmi, Merav ^c   Sas Chen, Aldema ^c   Muti, Paola ^d   Strano, Sabrina ^a   Yarden, Yosef ^c  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Cancer; Tumor suppressor microRNAs

Indexed keywords

LET 7C RNA; MICRORNA; MICRORNA 10B3P; MICRORNA 145; MICRORNA 204; MICRORNA 223; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

CANCER INHIBITION; CARCINOGENESIS; DOWN REGULATION; GENE LOCUS; GENE TARGETING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA SYNTHESIS; SIGNAL TRANSDUCTION;

CANCER; TUMOR SUPPRESSOR MICRORNAS;

ANIMALS; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84905108333     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.03.033     Document Type: Review

References (143)

1. L. Chin, and J.W. Gray Translating insights from the cancer genome into clinical practice Nature 452 2008 553 563
2. W.P. Kloosterman, and R.H. Plasterk The diverse functions of microRNAs in animal development and disease Dev. Cell 11 2006 441 450
3. G.A. Calin, C. Sevignani, C.D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini, and C.M. Croce Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc. Natl. Acad. Sci. USA 101 2004 2999 3004
4. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, and T.R. Golub MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
5. C. Sevignani, G.A. Calin, S.C. Nnadi, M. Shimizu, R.V. Davuluri, T. Hyslop, P. Demant, C.M. Croce, and L.D. Siracusa MicroRNA genes are frequently located near mouse cancer susceptibility loci Proc. Natl. Acad. Sci. USA 104 2007 8017 8022
6. P. Lopez-Serra, and M. Esteller DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer Oncogene 31 2012 1609 1622
7. S.A. Melo, and R. Kalluri Molecular pathways: microRNAs as cancer therapeutics Clin. Cancer Res. 18 2012 4234 4239
8. S.A. Melo, C. Moutinho, S. Ropero, G.A. Calin, S. Rossi, R. Spizzo, A.F. Fernandez, V. Davalos, A. Villanueva, G. Montoya, H. Yamamoto, S. Schwartz Jr.; and M. Esteller A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells Cancer Cell 18 2010 303 315
9. S.A. Melo, S. Ropero, C. Moutinho, L.A. Aaltonen, H. Yamamoto, G.A. Calin, S. Rossi, A.F. Fernandez, F. Carneiro, C. Oliveira, B. Ferreira, C.G. Liu, A. Villanueva, G. Capella, S. Schwartz Jr.; R. Shiekhattar, and M. Esteller A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function Nat. Genet. 41 2009 365 370
10. J.M. Hill, Y. Zhao, C. Clement, D.M. Neumann, and W.J. Lukiw HSV-1 infection of human brain cells induces miRNA-146a and Alzheimer-type inflammatory signaling Neuroreport 20 2009 1500 1505
11. N. Rosenfeld, R. Aharonov, E. Meiri, S. Rosenwald, Y. Spector, M. Zepeniuk, H. Benjamin, N. Shabes, S. Tabak, A. Levy, D. Lebanony, Y. Goren, E. Silberschein, N. Targan, A. Ben-Ari, S. Gilad, N. Sion-Vardy, A. Tobar, M. Feinmesser, O. Kharenko, O. Nativ, D. Nass, M. Perelman, A. Yosepovich, B. Shalmon, S. Polak-Charcon, E. Fridman, A. Avniel, I. Bentwich, Z. Bentwich, D. Cohen, A. Chajut, and I. Barshack MicroRNAs accurately identify cancer tissue origin Nat. Biotechnol. 26 2008 462 469
12. F. Biagioni, N. Bossel Ben-Moshe, G. Fontemaggi, V. Canu, F. Mori, B. Antoniani, A. Di Benedetto, R. Santoro, S. Germoni, F. De Angelis, A. Cambria, R. Avraham, G. Grasso, S. Strano, P. Muti, M. Mottolese, Y. Yarden, E. Domany, and G. Blandino miR-10ba master inhibitor of the cell cycle, is down-regulated in human breast tumours EMBO Mol. Med. 4 2012 1214 1229
13. R. Avraham, A. Sas-Chen, O. Manor, I. Steinfeld, R. Shalgi, G. Tarcic, N. Bossel, A. Zeisel, I. Amit, Y. Zwang, E. Enerly, H.G. Russnes, F. Biagioni, M. Mottolese, S. Strano, G. Blandino, A.L. Borresen-Dale, Y. Pilpel, Z. Yakhini, E. Segal, and Y. Yarden EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors Sci. Signal. 3 2010 (ra43)
14. R. Agami MicroRNAs, RNA binding proteins and cancer Eur. J. Clin. Invest. 40 2010 370 374
15. A. Barker, K.M. Giles, M.R. Epis, P.M. Zhang, F. Kalinowski, and P.J. Leedman Regulation of ErbB receptor signalling in cancer cells by microRNA Curr. Opin. Pharmacol. 10 2010 655 661
16. Y.T. Chou, H.H. Lin, Y.C. Lien, Y.H. Wang, C.F. Hong, Y.R. Kao, S.C. Lin, Y.C. Chang, S.Y. Lin, S.J. Chen, H.C. Chen, S.D. Yeh, and C.W. Wu EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF Cancer Res. 70 2010 8822 8831
17. M. Inui, G. Martello, and S. Piccolo MicroRNA control of signal transduction Nat. Rev. Mol. Cell. Biol. 11 2010 252 263
18. M. Shi, D. Liu, H. Duan, B. Shen, and N. Guo Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis Cancer Metastasis Rev. 29 2010 785 799
19. R. Visone, and C.M. Croce MiRNAs and cancer Am. J. Pathol. 174 2009 1131 1138
20. N. Rotllan, and C. Fernandez-Hernando MicroRNA regulation of cholesterol metabolism Cholesterol 2012 2012 847849
21. A. Davalos, L. Goedeke, P. Smibert, C.M. Ramirez, N.P. Warrier, U. Andreo, D. Cirera-Salinas, K. Rayner, U. Suresh, J.C. Pastor-Pareja, E. Esplugues, E.A. Fisher, L.O. Penalva, K.J. Moore, Y. Suarez, E.C. Lai, and C. Fernandez-Hernando MiR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling Proc. Natl. Acad. Sci. USA 108 2011 9232 9237
22. C. Vasilescu, S. Rossi, M. Shimizu, S. Tudor, A. Veronese, M. Ferracin, M.S. Nicoloso, E. Barbarotto, M. Popa, O. Stanciulea, M.H. Fernandez, D. Tulbure, C.E. Bueso-Ramos, M. Negrini, and G.A. Calin MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis PLoS One 4 2009 e7405
23. W.M. Schmidt, A.O. Spiel, B. Jilma, M. Wolzt, and M. Muller In vivo profile of the human leukocyte microRNA response to endotoxemia Biochem. Biophys. Res. Commun. 380 2009 437 441
24. R. Danger, C. Paul, M. Giral, A. Lavault, Y. Foucher, N. Degauque, A. Pallier, M. Durand, S. Castagnet, J.P. Duong Van Huyen, M. Delahousse, K. Renaudin, J.P. Soulillou, and S. Brouard Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection PLoS One 8 2013 e60702
25. S. Radom-Aizik, F. Zaldivar Jr.; S. Oliver, P. Galassetti, and D.M. Cooper Evidence for microRNA involvement in exercise-associated neutrophil gene expression changes J. Appl. Physiol. 109 2010 252 261
26. J.E. Rager, L. Smeester, I. Jaspers, K.G. Sexton, and R.C. Fry Epigenetic changes induced by air toxics: formaldehyde exposure alters miRNA expression profiles in human lung cells Environ. Health Perspect. 119 2011 494 500
27. B.K. Elamin, E. Callegari, L. Gramantieri, S. Sabbioni, and M. Negrini MicroRNA response to environmental mutagens in liver Mutat. Res. 717 2011 67 76
28. A. Izzotti, G.A. Calin, P. Arrigo, V.E. Steele, C.M. Croce, and S. De Flora Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke FASEB J. 23 2009 806 812
29. L. He, X. He, L.P. Lim, E. de Stanchina, Z. Xuan, Y. Liang, W. Xue, L. Zender, J. Magnus, D. Ridzon, A.L. Jackson, P.S. Linsley, C. Chen, S.W. Lowe, M.A. Cleary, and G.J. Hannon A microRNA component of the p53 tumour suppressor network Nature 447 2007 1130 1134
30. G. Mudduluru, P. Ceppi, R. Kumarswamy, G.V. Scagliotti, M. Papotti, and H. Allgayer Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer Oncogene 30 2011 2888 2899
31. S. Valastyan, and R.A. Weinberg MiR-31: a crucial overseer of tumor metastasis and other emerging roles Cell Cycle 9 2010 2124 2129
32. C. Piovan, D. Palmieri, G. Di Leva, L. Braccioli, P. Casalini, G. Nuovo, M. Tortoreto, M. Sasso, I. Plantamura, T. Triulzi, C. Taccioli, E. Tagliabue, M.V. Iorio, and C.M. Croce Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer Mol. Oncol. 6 2012 458 472
33. J. Zhou, S. Song, S. He, X. Zhu, Y. Zhang, B. Yi, B. Zhang, G. Qin, and D. Li MicroRNA-375 targets PDK1 in pancreatic carcinoma and suppresses cell growth through the Akt signaling pathway Int. J. Mol. Med. 33 2014 950 956
34. L. Miao, X. Xiong, Y. Lin, Y. Cheng, J. Lu, J. Zhang, and N. Cheng MiR-203 inhibits tumor cell migration and invasion via caveolin-1 in pancreatic cancer cells Oncol. Lett. 7 2014 658 662
35. C. Wang, X. Zheng, C. Shen, and Y. Shi MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells J. Exp. Clin. Cancer Res. 31 2012 58
36. N. Takeshita, M. Mori, M. Kano, I. Hoshino, Y. Akutsu, N. Hanari, Y. Yoneyama, N. Ikeda, Y. Isozaki, T. Maruyama, N. Akanuma, Y. Miyazawa, and H. Matsubara MiR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1 Int. J. Oncol. 41 2012 1653 1661
37. F. Chen, S.K. Hou, H.J. Fan, and Y.F. Liu MiR-15a-16 represses Cripto and inhibits NSCLC cell progression Mol. Cell. Biochem. 2014
38. D. Bonci, V. Coppola, M. Musumeci, A. Addario, R. Giuffrida, L. Memeo, L. D'Urso, A. Pagliuca, M. Biffoni, C. Labbaye, M. Bartucci, G. Muto, C. Peschle, and R. De Maria The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities Nat. Med. 14 2008 1271 1277
39. A. Cimmino, G.A. Calin, M. Fabbri, M.V. Iorio, M. Ferracin, M. Shimizu, S.E. Wojcik, R.I. Aqeilan, S. Zupo, M. Dono, L. Rassenti, H. Alder, S. Volinia, C.G. Liu, T.J. Kipps, M. Negrini, and C.M. Croce MiR-15 and miR-16 induce apoptosis by targeting BCL2 Proc. Natl. Acad. Sci. USA 102 2005 13944 13949
40. F. Biagioni, N. Bossel Ben-Moshe, G. Fontemaggi, Y. Yarden, E. Domany, and G. Blandino The locus of microRNA-10b: a critical target for breast cancer insurgence and dissemination Cell Cycle 12 2013
41. M.V. Iorio, M. Ferracin, C.G. Liu, A. Veronese, R. Spizzo, S. Sabbioni, E. Magri, M. Pedriali, M. Fabbri, M. Campiglio, S. Menard, J.P. Palazzo, A. Rosenberg, P. Musiani, S. Volinia, I. Nenci, G.A. Calin, P. Querzoli, M. Negrini, and C.M. Croce MicroRNA gene expression deregulation in human breast cancer Cancer Res. 65 2005 7065 7070
42. K. Kim, H.C. Lee, J.L. Park, M. Kim, S.Y. Kim, S.M. Noh, K.S. Song, J.C. Kim, and Y.S. Kim Epigenetic regulation of microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer Epigenetics 6 2011 740 751
43. L. Ma, F. Reinhardt, E. Pan, J. Soutschek, B. Bhat, E.G. Marcusson, J. Teruya-Feldstein, G.W. Bell, and R.A. Weinberg Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Nat. Biotechnol. 28 2010 341 347
44. L. Ma, J. Teruya-Feldstein, and R.A. Weinberg Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Nature 449 2007 682 688
45. P.N. Plummer, R. Freeman, R.J. Taft, J. Vider, M. Sax, B.A. Umer, D. Gao, C. Johns, J.S. Mattick, S.D. Wilton, V. Ferro, N.A. McMillan, A. Swarbrick, V. Mittal, and A.S. Mellick MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells Cancer Res. 73 2013 341 352
46. J. Lin, S. Teo, D.H. Lam, K. Jeyaseelan, and S. Wang MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme Cell Death Dis. 3 2012 e398
47. N. Bossel Ben-Moshe, R. Avraham, M. Kedmi, A. Zeisel, A. Yitzhaky, Y. Yarden, and E. Domany Context-specific microRNA analysis: identification of functional microRNAs and their mRNA targets Nucleic Acids Res. 40 2012 10614 10627
48. A.E. Pasquinelli, B.J. Reinhart, F. Slack, M.Q. Martindale, M.I. Kuroda, B. Maller, D.C. Hayward, E.E. Ball, B. Degnan, P. Muller, J. Spring, A. Srinivasan, M. Fishman, J. Finnerty, J. Corbo, M. Levine, P. Leahy, E. Davidson, and G. Ruvkun Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA Nature 408 2000 86 89
49. S. Roush, and F.J. Slack The let-7 family of microRNAs Trends Cell Biol. 18 2008 505 516
50. G.A. Calin, A. Cimmino, M. Fabbri, M. Ferracin, S.E. Wojcik, M. Shimizu, C. Taccioli, N. Zanesi, R. Garzon, R.I. Aqeilan, H. Alder, S. Volinia, L. Rassenti, X. Liu, C.G. Liu, T.J. Kipps, M. Negrini, and C.M. Croce MiR-15a and miR-16-1 cluster functions in human leukemia Proc. Natl. Acad. Sci. USA 105 2008 5166 5171
51. B.J. Reinhart, F.J. Slack, M. Basson, A.E. Pasquinelli, J.C. Bettinger, A.E. Rougvie, H.R. Horvitz, and G. Ruvkun The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans Nature 403 2000 901 906
52. F.G. Wulczyn, L. Smirnova, A. Rybak, C. Brandt, E. Kwidzinski, O. Ninnemann, M. Strehle, A. Seiler, S. Schumacher, and R. Nitsch Post-transcriptional regulation of the let-7 microRNA during neural cell specification FASEB J. 21 2007 415 426
53. X. Yang, Z.J. Rutnam, C. Jiao, D. Wei, Y. Xie, J. Du, L. Zhong, and B.B. Yang An anti-let-7 sponge decoys and decays endogenous let-7 functions Cell Cycle 11 2012 3097 3108
54. S.M. Johnson, H. Grosshans, J. Shingara, M. Byrom, R. Jarvis, A. Cheng, E. Labourier, K.L. Reinert, D. Brown, and F.J. Slack RAS is regulated by the let-7 microRNA family Cell 120 2005 635 647
55. S.Y. Cui, J.Y. Huang, Y.T. Chen, H.Z. Song, B. Feng, G.C. Huang, R. Wang, L.B. Chen, and W. De Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma Mol. Cancer Res. 11 2013 699 713
56. B.C. Christensen, B.J. Moyer, M. Avissar, L.G. Ouellet, S.L. Plaza, M.D. McClean, C.J. Marsit, and K.T. Kelsey A let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers Carcinogenesis 30 2009 1003 1007
57. W. Zhang, T. Winder, Y. Ning, A. Pohl, D. Yang, M. Kahn, G. Lurje, M.J. Labonte, P.M. Wilson, M.A. Gordon, S. Hu-Lieskovan, D.J. Mauro, C. Langer, E.K. Rowinsky, and H.J. Lenz A let-7 microRNA-binding site polymorphism in 3′-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy Ann. Oncol. 22 2011 104 109
58. Y. Peng, J. Laser, G. Shi, K. Mittal, J. Melamed, P. Lee, and J.J. Wei Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma Mol. Cancer Res. 6 2008 663 673
59. G. Tzur, A. Israel, A. Levy, H. Benjamin, E. Meiri, Y. Shufaro, K. Meir, E. Khvalevsky, Y. Spector, N. Rojansky, Z. Bentwich, B.E. Reubinoff, and E. Galun Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development PLoS One 4 2009 e7511
60. N. Nadiminty, R. Tummala, W. Lou, Y. Zhu, X.B. Shi, J.X. Zou, H. Chen, J. Zhang, X. Chen, J. Luo, R.W. deVere White, H.J. Kung, C.P. Evans, and A.C. Gao MicroRNA let-7c is downregulated in prostate cancer and suppresses prostate cancer growth PLoS One 7 2012 e32832
61. E.P. Brennan, K.A. Nolan, E. Borgeson, O.S. Gough, C.M. McEvoy, N.G. Docherty, D.F. Higgins, M. Murphy, D.M. Sadlier, S.T. Ali-Shah, P.J. Guiry, D.A. Savage, A.P. Maxwell, F. Martin, C. Godson, and Consortium, G. Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFbetaR1 J. Am. Soc. Nephrol. 24 2013 627 637
62. A. Pelosi, S. Careccia, V. Lulli, P. Romania, G. Marziali, U. Testa, S. Lavorgna, F. Lo-Coco, M.C. Petti, B. Calabretta, M. Levrero, G. Piaggio, and M.G. Rizzo MiRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia Oncogene 32 2013 3648 3654
63. Y.M. Shah, K. Morimura, Q. Yang, T. Tanabe, M. Takagi, and F.J. Gonzalez Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation Mol. Cell. Biol. 27 2007 4238 4247
64. B. Zhao, H. Han, J. Chen, Z. Zhang, S. Li, F. Fang, Q. Zheng, Y. Ma, J. Zhang, N. Wu, and Y. Yang MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3 Cancer Lett. 342 2014 43 51
65. H.B. Han, J. Gu, H.J. Zuo, Z.G. Chen, W. Zhao, M. Li, D.B. Ji, Y.Y. Lu, and Z.Q. Zhang Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer J. Pathol. 226 2012 544 555
66. H. Yamada, K. Yanagisawa, S. Tokumaru, A. Taguchi, Y. Nimura, H. Osada, M. Nagino, and T. Takahashi Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer Genes Chromosomes Cancer 47 2008 810 818
67. E. Piskounova, C. Polytarchou, J.E. Thornton, R.J. LaPierre, C. Pothoulakis, J.P. Hagan, D. Iliopoulos, and R.I. Gregory Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms Cell 147 2011 1066 1079
68. I. Heo, C. Joo, J. Cho, M. Ha, J. Han, and V.N. Kim Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA Mol. Cell 32 2008 276 284
69. I. Heo, C. Joo, Y.K. Kim, M. Ha, M.J. Yoon, J. Cho, K.H. Yeom, J. Han, and V.N. Kim TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation Cell 138 2009 696 708
70. J.E. Thornton, and R.I. Gregory How does Lin28 let-7 control development and disease? Trends Cell Biol. 22 2012 474 482
71. E.G. Moss, and L. Tang Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites Dev. Biol. 258 2003 432 442
72. Y. Guo, Y. Chen, H. Ito, A. Watanabe, X. Ge, T. Kodama, and H. Aburatani Identification and characterization of lin-28 homolog B (LIN28B) in human hepatocellular carcinoma Gene 384 2006 51 61
73. P.Y. Wang, Y.X. Sun, S. Zhang, M. Pang, H.H. Zhang, S.Y. Gao, C. Zhang, C.J. Lv, and S.Y. Xie Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors FEBS Lett. 587 2013 2675 2681
74. J.P. Thiery, H. Acloque, R.Y. Huang, and M.A. Nieto Epithelial- mesenchymal transitions in development and disease Cell 139 2009 871 890
75. C.Z. Chen, L. Li, H.F. Lodish, and D.P. Bartel MicroRNAs modulate hematopoietic lineage differentiation Science 303 2004 83 86
76. F. Fazi, A. Rosa, A. Fatica, V. Gelmetti, M.L. De Marchis, C. Nervi, and I. Bozzoni A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis Cell 123 2005 819 831
77. L. Vian, M. Di Carlo, E. Pelosi, F. Fazi, S. Santoro, A.M. Cerio, A. Boe, V. Rotilio, M. Billi, S. Racanicchi, U. Testa, F. Grignani, and C. Nervi Transcriptional fine-tuning of microRNA-223 levels directs lineage choice of human hematopoietic progenitors Cell Death Differ. 21 2014 290 301
78. C. Nervi, F. Fazi, A. Rosa, A. Fatica, and I. Bozzoni Emerging role for microRNAs in acute promyelocytic leukemia Curr. Top. Microbiol. Immunol. 313 2007 73 84
79. G. Zardo, A. Ciolfi, L. Vian, L.M. Starnes, M. Billi, S. Racanicchi, C. Maresca, F. Fazi, L. Travaglini, N. Noguera, M. Mancini, M. Nanni, G. Cimino, F. Lo-Coco, F. Grignani, and C. Nervi Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression Blood 119 2012 4034 4046
80. F. Fazi, S. Racanicchi, G. Zardo, L.M. Starnes, M. Mancini, L. Travaglini, D. Diverio, E. Ammatuna, G. Cimino, F. Lo-Coco, F. Grignani, and C. Nervi Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein Cancer Cell 12 2007 457 466
81. J.A. Pulikkan, V. Dengler, P.S. Peramangalam, A.A. Peer Zada, C. Muller-Tidow, S.K. Bohlander, D.G. Tenen, and G. Behre Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia Blood 115 2010 1768 1778
82. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat. Cell Biol. 9 2007 654 659
83. N. Ismail, Y. Wang, D. Dakhlallah, L. Moldovan, K. Agarwal, K. Batte, P. Shah, J. Wisler, T.D. Eubank, S. Tridandapani, M.E. Paulaitis, M.G. Piper, and C.B. Marsh Macrophage microvesicles induce macrophage differentiation and miR-223 transfer Blood 121 2013 984 995
84. A. Aucher, D. Rudnicka, and D.M. Davis MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation J. Immunol. 191 2013 6250 6260
85. C.Y. Jia, H.H. Li, X.C. Zhu, Y.W. Dong, D. Fu, Q.L. Zhao, W. Wu, and X.Z. Wu MiR-223 suppresses cell proliferation by targeting IGF-1R PLoS One 6 2011 e27008
86. Q.W. Wong, R.W. Lung, P.T. Law, P.B. Lai, K.Y. Chan, K.F. To, and N. Wong MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1 Gastroenterology 135 2008 257 269
87. S. Masciarelli, G. Fontemaggi, S. Di Agostino, S. Donzelli, E. Carcarino, S. Strano, and G. Blandino Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells Oncogene 33 2013 1601 1608
88. W. Nian, X. Ao, Y. Wu, Y. Huang, J. Shao, Y. Wang, Z. Chen, F. Chen, and D. Wang MiR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2 Oncol. Lett. 6 2013 359 366
89. L. Wu, H. Li, C.Y. Jia, W. Cheng, M. Yu, M. Peng, Y. Zhu, Q. Zhao, Y.W. Dong, K. Shao, A. Wu, and X.Z. Wu MicroRNA-223 regulates FOXO1 expression and cell proliferation FEBS Lett. 586 2012 1038 1043
90. M.R. Mansour, T. Sanda, L.N. Lawton, X. Li, T. Kreslavsky, C.D. Novina, M. Brand, A. Gutierrez, M.A. Kelliher, C.H. Jamieson, H. von Boehmer, R.A. Young, and A.T. Look The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia J. Exp. Med. 210 2013 1545 1557
91. K.J. Mavrakis, J. Van Der Meulen, A.L. Wolfe, X. Liu, E. Mets, T. Taghon, A.A. Khan, M. Setty, P. Rondou, P. Vandenberghe, E. Delabesse, Y. Benoit, N.B. Socci, C.S. Leslie, P. Van Vlierberghe, F. Speleman, and H.G. Wendel A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL) Nat. Genet. 43 2011 673 678
92. A. Iio, Y. Nakagawa, I. Hirata, T. Naoe, and Y. Akao Identification of non-coding RNAs embracing microRNA-143/145 cluster Mol. Cancer 9 2010 136
93. M.Z. Michael, S.M. O' Connor, N.G. van Holst Pellekaan, G.P. Young, and R.J. James Reduced accumulation of specific microRNAs in colorectal neoplasia Mol. Cancer Res. 1 2003 882 891
94. D.T. Starczynowski, F. Kuchenbauer, B. Argiropoulos, S. Sung, R. Morin, A. Muranyi, M. Hirst, D. Hogge, M. Marra, R.A. Wells, R. Buckstein, W. Lam, R.K. Humphries, and A. Karsan Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype Nat. Med. 16 2010 49 58
95. M. Sachdeva, S. Zhu, F. Wu, H. Wu, V. Walia, S. Kumar, R. Elble, K. Watabe, and Y.Y. Mo P53 represses c-Myc through induction of the tumor suppressor miR-145 Proc. Natl. Acad. Sci. USA 106 2009 3207 3212
96. S.O. Suh, Y. Chen, M.S. Zaman, H. Hirata, S. Yamamura, V. Shahryari, J. Liu, Z.L. Tabatabai, S. Kakar, G. Deng, Y. Tanaka, and R. Dahiya MicroRNA-145 is regulated by DNA methylation and p53 gene mutation in prostate cancer Carcinogenesis 32 2011 772 778
97. M. Sachdeva, Q. Liu, J. Cao, Z. Lu, and Y.Y. Mo Negative regulation of miR-145 by C/EBP-beta through the Akt pathway in cancer cells Nucleic Acids Res. 40 2012 6683 6692
98. H.I. Suzuki, K. Yamagata, K. Sugimoto, T. Iwamoto, S. Kato, and K. Miyazono Modulation of microRNA processing by p53 Nature 460 2009 529 533
99. A. Iio, T. Takagi, K. Miki, T. Naoe, A. Nakayama, and Y. Akao DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells Biochim. Biophys. Acta 1829 2013 1102 1110
100. M. Sachdeva, and Y.Y. Mo MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1 Cancer Res. 70 2010 378 387
101. M. Gotte, C. Mohr, C.Y. Koo, C. Stock, A.K. Vaske, M. Viola, S.A. Ibrahim, S. Peddibhotla, Y.H. Teng, J.Y. Low, K. Ebnet, L. Kiesel, and G.W. Yip MiR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness Oncogene 29 2010 6569 6580
102. H. Zhang, J. Pu, T. Qi, M. Qi, C. Yang, S. Li, K. Huang, L. Zheng, and Q. Tong MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha Oncogene 33 2014 387 397
103. P. Gao, A.Y. Xing, G.Y. Zhou, T.G. Zhang, J.P. Zhang, C. Gao, H. Li, and D.B. Shi The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer Oncogene 32 2013 491 501
104. M. Fuse, N. Nohata, S. Kojima, S. Sakamoto, T. Chiyomaru, K. Kawakami, H. Enokida, M. Nakagawa, Y. Naya, T. Ichikawa, and N. Seki Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1 Int. J. Oncol. 38 2011 1093 1101
105. B. Shi, L. Sepp-Lorenzino, M. Prisco, P. Linsley, T. deAngelis, and R. Baserga Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells J. Biol. Chem. 282 2007 32582 32590
106. L.H. Gregersen, A.B. Jacobsen, L.B. Frankel, J. Wen, A. Krogh, and A.H. Lund MicroRNA-145 targets YES and STAT1 in colon cancer cells PLoS One 5 2010 e8836
107. Q. Xu, L.Z. Liu, X. Qian, Q. Chen, Y. Jiang, D. Li, L. Lai, and B.H. Jiang MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis Nucleic Acids Res. 40 2012 761 774
108. W.C. Cho, A.S. Chow, and J.S. Au MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1 RNA Biol. 8 2011 125 131
109. N. Yanaihara, N. Caplen, E. Bowman, M. Seike, K. Kumamoto, M. Yi, R.M. Stephens, A. Okamoto, J. Yokota, T. Tanaka, G.A. Calin, C.G. Liu, C.M. Croce, and C.C. Harris Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 2006 189 198
110. C. Zou, Q. Xu, F. Mao, D. Li, C. Bian, L.Z. Liu, Y. Jiang, X. Chen, Y. Qi, X. Zhang, X. Wang, Q. Sun, H.F. Kung, M.C. Lin, A. Dress, F. Wardle, B.H. Jiang, and L. Lai MiR-145 inhibits tumor angiogenesis and growth by N-RAS and VEGF Cell Cycle 11 2012 2137 2145
111. S. Wang, C. Bian, Z. Yang, Y. Bo, J. Li, L. Zeng, H. Zhou, and R.C. Zhao MiR-145 inhibits breast cancer cell growth through RTKN Int. J. Oncol. 34 2009 1461 1466
112. R. Spizzo, M.S. Nicoloso, L. Lupini, Y. Lu, J. Fogarty, S. Rossi, B. Zagatti, M. Fabbri, A. Veronese, X. Liu, R. Davuluri, C.M. Croce, G. Mills, M. Negrini, and G.A. Calin MiR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells Cell Death Differ. 17 2010 246 254
113. J. Zhang, Q. Sun, Z. Zhang, S. Ge, Z.G. Han, and W.T. Chen Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop Oncogene 32 2013 61 69
114. C. Polytarchou, D. Iliopoulos, and K. Struhl An integrated transcriptional regulatory circuit that reinforces the breast cancer stem cell state Proc. Natl. Acad. Sci. USA 109 2012 14470 14475
115. N. Xu, T. Papagiannakopoulos, G. Pan, J.A. Thomson, and K.S. Kosik MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells Cell 137 2009 647 658
116. M. Cioce, F. Ganci, V. Canu, A. Sacconi, F. Mori, C. Canino, E. Korita, B. Casini, G. Alessandrini, A. Cambria, M.A. Carosi, R. Blandino, V. Panebianco, F. Facciolo, P. Visca, S. Volinia, P. Muti, S. Strano, C.M. Croce, H.I. Pass, and G. Blandino Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma Oncogene 18 2013
117. O.A. Kent, R.R. Chivukula, M. Mullendore, E.A. Wentzel, G. Feldmann, K.H. Lee, S. Liu, S.D. Leach, A. Maitra, and J.T. Mendell Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway Genes Dev. 24 2010 2754 2759
118. O.A. Kent, K. Fox-Talbot, and M.K. Halushka RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets Oncogene 32 2013 2576 2585
119. A. Pagliuca, C. Valvo, E. Fabrizi, S. di Martino, M. Biffoni, D. Runci, S. Forte, R. De Maria, and L. Ricci-Vitiani Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression Oncogene 32 2013 4806 4813
120. X. Chen, J. Gong, H. Zeng, N. Chen, R. Huang, Y. Huang, L. Nie, M. Xu, J. Xia, F. Zhao, W. Meng, and Q. Zhou MicroRNA145 targets BNIP3 and suppresses prostate cancer progression Cancer Res. 70 2010 2728 2738
121. D. Ren, M. Wang, W. Guo, X. Zhao, X. Tu, S. Huang, X. Zou, and X. Peng Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR145 Int. J. Oncol. 42 2013 1473 1481
122. M. Hart, S. Wach, E. Nolte, J. Szczyrba, R. Menon, H. Taubert, A. Hartmann, R. Stoehr, W. Wieland, F.A. Grasser, and B. Wullich The proto-oncogene ERG is a target of microRNA miR-145 in prostate cancer FEBS J. 280 2013 2105 2116
123. F.E. Wang, C. Zhang, A. Maminishkis, L. Dong, C. Zhi, R. Li, J. Zhao, V. Majerciak, A.B. Gaur, S. Chen, and S.S. Miller MicroRNA-204/211 alters epithelial physiology FASEB J. 24 2010 1552 1571
124. J. Oberwinkler TRPM3, a biophysical enigma? Biochem. Soc. Trans. 35 2007 89 90
125. I. Conte, S. Carrella, R. Avellino, M. Karali, R. Marco-Ferreres, P. Bovolenta, and S. Banfi MiR-204 is required for lens and retinal development via Meis2 targeting Proc. Natl. Acad. Sci. USA 107 2010 15491 15496
126. O. Shaham, K. Gueta, E. Mor, P. Oren-Giladi, D. Grinberg, Q. Xie, A. Cvekl, N. Shomron, N. Davis, M. Keydar-Prizant, S. Raviv, M. Pasmanik-Chor, R.E. Bell, C. Levy, R. Avellino, S. Banfi, I. Conte, and R. Ashery-Padan Pax6 regulates gene expression in the vertebrate lens through miR-204 PLoS Genet. 9 2013 e1003357
127. A. Sacconi, F. Biagioni, V. Canu, F. Mori, A. Di Benedetto, L. Lorenzon, C. Ercolani, S. Di Agostino, A.M. Cambria, S. Germoni, G. Grasso, R. Blandino, V. Panebianco, V. Ziparo, O. Federici, P. Muti, S. Strano, F. Carboni, M. Mottolese, M. Diodoro, E. Pescarmona, A. Garofalo, and G. Blandino MiR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer Cell Death Dis. 3 2012 e423
128. E. Staub, J. Grone, D. Mennerich, S. Ropcke, I. Klamann, B. Hinzmann, E. Castanos-Velez, B. Mann, C. Pilarsky, T. Brummendorf, B. Weber, H.J. Buhr, and A. Rosenthal A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer Mol. Cancer 5 2006 37
129. V. Balachandar, B. Lakshman Kumar, K. Sasikala, P. Manikantan, R. Sangeetha, and S. Mohana Devi Identification of a high frequency of chromosomal rearrangements in the centromeric regions of prostate cancer patients J. Zhejiang Univ. Sci. B 8 2007 638 646
130. L. Zhang, X. Wang, and P. Chen MiR-204 down regulates SIRT1 and reverts SIRT1-induced epithelial-mesenchymal transition, anoikis resistance and invasion in gastric cancer cells BMC Cancer 13 2013 290
131. Y. Lee, X. Yang, Y. Huang, H. Fan, Q. Zhang, Y. Wu, J. Li, R. Hasina, C. Cheng, M.W. Lingen, M.B. Gerstein, R.R. Weichselbaum, H.R. Xing, and Y.A. Lussier Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis PLoS Comput. Biol. 6 2010 e1000730
132. W. Bao, H.H. Wang, F.J. Tian, X.Y. He, M.T. Qiu, J.Y. Wang, H.J. Zhang, L.H. Wang, and X.P. Wan A TrkB-STAT3-miR-204-5p regulatory circuitry controls proliferation and invasion of endometrial carcinoma cells Mol. Cancer 12 2013 155
133. Z. Ying, Y. Li, J. Wu, X. Zhu, Y. Yang, H. Tian, W. Li, B. Hu, S.Y. Cheng, and M. Li Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype Cancer Res. 73 2013 990 999
134. O. Mikhaylova, Y. Stratton, D. Hall, E. Kellner, B. Ehmer, A.F. Drew, C.A. Gallo, D.R. Plas, J. Biesiada, J. Meller, and M.F. Czyzyk-Krzeska VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma Cancer Cell 21 2012 532 546
135. S. Valastyan, A. Chang, N. Benaich, and F. Reinhardt Weinberg RA: concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis Cancer Res. 70 2010 5147 5154
136. P.Y. Wang, Y.X. Sun, S. Zhang, M. Pang, H.H. Zhang, S.Y. Gao, C. Zhang, C.J. Lv, and S.Y. Xie Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors FEBS Lett. 587 2013 2675 2681
137. T. Yang, Z.M. Zheng, X.N. Li, Z.F. Li, Y. Wang, Y.F. Geng, L. Bai, and X.B. Zhang MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells Exp. Biol. Med. (Maywood) 238 2013 1024 1032
138. B.S. Huang, Q.Z. Luo, Y. Han, X.B. Li, L.J. Cao, and L.X. Wu microRNA-223 promotes the growth and invasion of glioblastoma cells by targeting tumor suppressor PAX6 Oncol. Rep. 30 2013 2263 2269
139. B. Gong, H. Hu, J. Chen, S. Cao, J. Yu, J. Xue, F. Chen, Y. Cai, H. He, and L. Zhang Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells Biomed. Pharmacother. 67 2013 629 636
140. X. Li, Y. Zhang, H. Zhang, X. Liu, T. Gong, M. Li, L. Sun, G. Ji, Y. Shi, and Z. Han et al. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3 Mol. Cancer Res. 9 2011 824 833
141. S. Li, Z. Li, F. Guo, X. Qin, B. Liu, Z. Lei, Z. Song, L. Sun, H.T. Zhang, J. You, and Q. Zhou miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma J. Biomed. Sci. 18 2011 24
142. Z. Chen, V. Sangwan, S. Banerjee, T. Mackenzie, V. Dudeja, X. Li, H. Wang, S.M. Vickers, and A.K. Saluja miR-204 mediated loss of Myeloid cell leukemia-1 results in pancreatic cancer cell death Mol. Cancer 12 2013 105
143. S. Pollari, S.K. Leivonen, M. Perala, V. Fey, and S.M. Kakonen Kallioniemi O: Identification of microRNAs inhibiting TGF-beta-induced IL-11 production in bone metastatic breast cancer cells PLoS One 7 2012 e37361